Charles River Laboratories International (CRL) Other Non-Current Liabilities (2016 - 2025)
Charles River Laboratories International (CRL) has 14 years of Other Non-Current Liabilities data on record, last reported at $138.3 million in Q4 2025.
- For Q4 2025, Other Non-Current Liabilities fell 29.15% year-over-year to $138.3 million; the TTM value through Dec 2025 reached $138.3 million, down 29.15%, while the annual FY2025 figure was $138.3 million, 29.15% down from the prior year.
- Other Non-Current Liabilities reached $138.3 million in Q4 2025 per CRL's latest filing, down from $189.5 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $242.9 million in Q4 2021 and bottomed at $138.3 million in Q4 2025.
- Average Other Non-Current Liabilities over 5 years is $199.1 million, with a median of $195.2 million recorded in 2024.
- Peak YoY movement for Other Non-Current Liabilities: skyrocketed 37.19% in 2024, then dropped 29.15% in 2025.
- A 5-year view of Other Non-Current Liabilities shows it stood at $242.9 million in 2021, then decreased by 28.02% to $174.8 million in 2022, then grew by 27.67% to $223.2 million in 2023, then decreased by 12.54% to $195.2 million in 2024, then fell by 29.15% to $138.3 million in 2025.
- Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $138.3 million in Q4 2025, $189.5 million in Q3 2025, and $185.2 million in Q2 2025.